Table 1.
Age | E13 | E14 | E15 | E17 | P0 |
---|---|---|---|---|---|
nCi/mg tissue equivalent (mean ± SEM) | |||||
D1-like binding | 0.065 ± 0.023 | 1.552 ± 0.103 | 2.09 ± 0.217 | 4.068 ± 0.575 | 5.466 ± 0.569 |
D2-like binding | 0.017 ± 0.014 | 0.262 ± 0.01 | 0.224 ± 0.037 | 0.893 ± 0.181 | 1.06 ± 0.213 |
Femtomoles of bound ligand per milligram of tissue | |||||
D1-like binding | 0.927 | 22.038 | 29.680 | 57.769 | 77.6223 |
D2-like binding | 0.219 | 3.295 | 2.823 | 11.253 | 13.360 |
The binding intensities were standardized to nanocuries per milligram (nCi/mg) of tissue equivalent across the different replications by calibration against tritiated polymer standards. Then, the nCi/mg of tissue equivalent values were converted to femtomoles of bound ligand per milligram of tissue on the basis of the specific activity of the antagonists used. Both D1- and D2-like binding increases during development.